Moolec Science (NASDAQ:MLEC) Trading 0.9% Higher – Here’s Why

Posted by Defense World Staff on Jul 21st, 2026

Shares of Moolec Science SA (NASDAQ:MLEC – Get Free Report) were up 0.9% on Monday . The company traded as high as $6.85 and last traded at $6.60. Approximately 2,656 shares were traded during mid-day trading, a decline of 64% from the average session volume of 7,322 shares. The stock had previously closed at $6.54.

Analysts Set New Price Targets

Separately, Wall Street Zen raised Moolec Science from a “sell” rating to a “hold” rating in a report on Saturday, May 16th.

Get Our Latest Research Report on MLEC

Moolec Science Price Performance

The company has a current ratio of 0.15, a quick ratio of 0.08 and a debt-to-equity ratio of 0.79. The company has a market capitalization of $4.82 million, a P/E ratio of -0.20 and a beta of 0.26. The company has a 50 day moving average price of $7.62 and a 200 day moving average price of $7.86.

Moolec Science (NASDAQ:MLEC – Get Free Report) last posted its quarterly earnings results on Thursday, May 14th. The company reported $47.49 earnings per share for the quarter. The business had revenue of $2.62 million during the quarter.

Hedge Funds Weigh In On Moolec Science

An institutional investor recently bought a new position in Moolec Science stock. Citadel Advisors LLC bought a new position in shares of Moolec Science SA (NASDAQ:MLEC – Free Report) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 36,218 shares of the company’s stock, valued at approximately $36,000. Citadel Advisors LLC owned about 0.90% of Moolec Science as of its most recent filing with the Securities and Exchange Commission. Hedge funds and other institutional investors own 0.07% of the company’s stock.

Moolec Science Company Profile

(Get Free Report)

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.